Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 6:52 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1369–1392 of 3,871 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: FAST Clear all

Conditions: Healthy
Interventions: Loperamide HCl 2 mg and simethicone 125 mg tablets; Drug
Lead sponsor: Ranbaxy Laboratories Limited; Industry
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004
U.S. locations: 1
States / cities: Saint Charles, Missouri

Conditions: Healthy Volunteer
Interventions: BIIB122, Rabeprazole; Drug
Lead sponsor: Biogen; Industry
Eligibility: 30 Years to 80 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Pregnancy, Contraception
Interventions: Quick start oral contraceptive initiation; Behavioral
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: Up to 24 Years · Female only
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2005
U.S. locations: 3
States / cities: Atlanta, Georgia • New York, New York • Dallas, Texas

Conditions: Healthy
Interventions: Gabapentin 400 mg capsules, NEURONTIN® 400 mg capsules; Drug
Lead sponsor: Actavis Inc.; Industry
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1998
U.S. locations: 1
States / cities: Saint Charles, Missouri

Conditions: Traumatic Brain Injury, Concussion, Brain
Interventions: Blink Reflexometer; Device
Lead sponsor: Blinktbi, Inc.; Industry
Eligibility: 14 Years and older
Enrollment: 477 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 5
States / cities: Charlotte, North Carolina • Hershey, Pennsylvania • Charleston, South Carolina + 2 more

Conditions: Diabetes, Gastric Bypass
Interventions: Mixed Meal Tolerance test, Hyperglycemic clamp; Procedure
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 19 Years to 65 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Healthy Volunteer
Interventions: ABBV-101; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Grayslake, Illinois

Conditions: Impulse Control Disorder, Parkinson Disease
Interventions: rTMS Active, rTMS Sham; Device
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Covid19
Interventions: Project ECHO; Other
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 136 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Healthy
Interventions: Imagined muscle contractions; Behavioral
Lead sponsor: Kennesaw State University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Kennesaw, Georgia

Conditions: Osteoarthritis
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 40 Years and older · Female only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Type 2 Diabetes, Obesity
Interventions: discontinuation of sugar sweetened beverages; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Relapse Remitting Multiple Sclerosis
Interventions: Not listed
Lead sponsor: Oklahoma Medical Research Foundation; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Chronic Pain
Interventions: Oxymorphone ER; Drug
Lead sponsor: MedVadis Research Corporation; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Wellesley Hills, Massachusetts

Conditions: Cancer, Chemotherapy
Interventions: Virtual reality therapy, Questionnaires, Measure heart rate, Cyber sickness measurement; Behavioral · Procedure
Lead sponsor: Cody Stansel; Other
Eligibility: 18 Years and older
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Obesity
Interventions: Low-Carbohydrate Diet, Intermittent Energy Restriction, Hunger Training; Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Arterial Stiffness in Youth With Type 1 Diabetes
Interventions: Pre-meal bolus, No meal bolus; Drug
Lead sponsor: University of Florida; Other
Eligibility: 8 Years to 21 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Affective Symptoms, Empathy
Interventions: Facial Affect Sensitivity Training (FAST), Implicit Gaze Training task (Active control condition); Behavioral
Lead sponsor: University of Alabama, Tuscaloosa; Other
Eligibility: 6 Years to 11 Years
Enrollment: 161 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Tuscaloosa, Alabama

Conditions: Fatty Liver
Interventions: High fat meal, Morphine; Other · Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 65 Years
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Gout
Interventions: D-0120; Drug
Lead sponsor: InventisBio Co., Ltd; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Daytona Beach, Florida

Conditions: Insulinoma
Interventions: Intraoperative ultrasound; Procedure
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: Not listed
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2006
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Hepatic Impairment
Interventions: WCK 2349; Drug
Lead sponsor: Wockhardt; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Medical Malpractice, Patient Safety
Interventions: Training and in-office coaching; Other
Lead sponsor: Massachusetts Department of Health; Government
Eligibility: 18 Years and older
Enrollment: 213 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: PreDiabetes
Interventions: Intralipid and heparin, Saline; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 25 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Search by objective public record fields.

Bioequivalence Study of Loperamide Hydrochloride 2 mg and Simethicone 125 mg Tablet Under Fasting Conditions

A Study to Assess the Potential for Gastric-pH Dependent Drug-Drug Interactions of BIIB122 With a Proton Pump Inhibitor in Healthy Participants

Quick Start Approach to Birth Control Pills

A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Fasting Conditions

Understanding Concussion/Mild Traumatic Brain Injury

Glucose Metabolism in the Immediate and Short Term Follow up After Bariatric Surgery

A Study to Assess How Food Affects the Movement of Oral ABBV-101 Through the Body of Healthy Adult Participants

rTMS Over the Dorsolateral Prefrontal Cortex for the Treatment of Impulse Control Disorders in Parkinson's Disease

COVID-19 Project ECHO in Nursing Homes

Influence of Fast and Slow Imagined Muscle Contractions on Muscle Function or Central Nervous System Properties

A Longitudinal Study of Osteoarthritis (OA) Disease Progression Measured by MRI, dGEMRIC, and Radiography

Effect of Discontinuation of Sugar Sweetened Beverages

Early Versus Delayed Start of Ocrevus Zunovo for Relapsing Multiple Sclerosis

Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive Functioning

Virtual Reality on Pain, Stress, and Affect in the Infusion Clinic

Testing the Effect of Multiple Weight Management Modalities for Chronic Disease Risk Reduction in a Clinical Setting

Arterial Stiffness in Type I Diabetes Mellitus

Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits

Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver Disease

D-0120 Safety and PK/PD, Food Effect Study in Healthy Volunteers

Laparoscopy to Remove Pancreatic Tumors (Insulinomas)

Pharmacokinetics of WCK 2349 In Patients With Hepatic Impairment

Proactive Reduction of Outpatient Malpractice: Increasing Safety, Efficiency, and Satisfaction

Insulin and Insulin Pulses During Fasting